School of Medicine
Showing 1-77 of 77 Results
-
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Nilima Ragavan
Clinical Professor, Pediatrics - Neonatal and Developmental Medicine
BioDr Nilima Ragavan is an experienced clinician who has expertise in the care of newborns ranging from critically ill to well babies. She is passionate about education and is the director of the Stanford pediatric resident rotation in the neonatal intensive care unit. She has led several multi disciplinary teams to India, and has organized and conducted international neonatal and perinatal conferences. She is a member of the palliative care team and serves as a mentor to junior faculty. She is the medical director of the Packard Special Care nursery at Sequoia, and also attends in the NICU at Stanford.
-
Alireza Raissadati
Postdoctoral Medical Fellow, Cardiology
Fellow in Pediatrics - CardiologyBioAlireza Raissadati, MD, PhD is a fellow in pediatric cardiology at Lucile Packard Children's Hospital, Stanford. He obtained his medical degree, PhD in medicine, and PhD in biotechnology from University of Helsinki. His research focused on population-based long-term outcomes of patients following congenital heart surgery and the role of vascular growth factors and gene vectors as management strategies for heart transplant rejection.
Dr. Raissadati completed his pediatric residency training at Boston Children's Hospital/Harvard Medical School and Boston Medical Center in Boston, MA. His clinical interest lies in treating pediatric patients with heart failure and following heart transplantation. His research is focused on understanding the intricacies of heart transplant rejection to find new therapeutic targets for acute rejection and coronary artery vasculopathy of the heart transplant. -
Varsha Rajesh
Research Associate in Functional Genomics, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional at Translational Genomics of Diabetes Lab.
-
Sneha Ramakrishna
Assistant Professor of Pediatrics (Hematology/Oncology)
BioSneha Ramakrishna obtained her B. A. from the University of Chicago and her M.D. from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. In medical school, through the Howard Hughes Medical Research Scholar Award, she joined Dr. Crystal Mackall’s laboratory, where she designed and developed various GD2 CAR-Ts and tested them in preclinical models. During her residency training in Pediatrics at the Children’s Hospital of Philadelphia, she cared for some of the first patients treated with CD19 CAR T cells, learning the power of this therapy first-hand. During her fellowship in Pediatric Hematology/Oncology at the Johns Hopkins/National Cancer Institute combined program, she worked with Dr. Terry Fry. She evaluated the mechanism of CD22 CAR T cell relapse in patients by developing an antigen escape model and establishing a deeper understanding of the effects of antigen density on CAR-T phenotype, expansion, and persistence (Fry…Ramakrishna…Mackall Nat Med, 2018; Ramakrishna, et al., Clinical Cancer Research, 2019). Since arriving at Stanford, Dr. Ramakrishna leads an interdisciplinary team that designs, develops, and successfully implements a robust correlative science platform for our novel CAR-T therapies. Analyzing patient samples from our first-in-human GD2 CAR-T trial (NCT04196413) treating a universally fatal cancer, diffuse midline glioma (DMG), we identified that intracerebroventricular CAR-T administration correlates with enhanced pro-inflammatory cytokines and reduced immunosuppressive cell populations in cerebrospinal fluid as compared to intravenous CAR-T administration (Majzner*, Ramakrishna*, et al., Nature 2022 *co-first authors). Her research program evaluates unique sets of patient samples using novel single-cell immune profiling to identify the drivers of CAR-T success or failure. Building on these findings, her team will assess approaches to enhance CAR-T efficacy and translate these findings to the clinic.
Clinically, Dr. Ramakrishna cares for children with solid tumors and treats hematologic, solid, and brain tumor pediatric patients with CAR T cell therapies in the Cancer Cellular Therapies program. -
Mahalakshmi Ramamurthy
Postdoctoral Scholar, Developmental Behavioral Pediatrics
BioI am a postdoctoral scholar working with Dr. Jason Yeatman. With a background in optometry, vision science, psychophysics and cognitive neuroscience my long-term goal is to study the intersection of basic visual mechanisms and various neurodevelopmental disorders and to extend this understanding in creating effective early screening tools, and in advancing evidence-based therapeutic and remediation programs. Inherent to this interest is the need for developmental data in large and demographically diverse populations. I strongly believe that such inclusive research not only contributes to scientific advancements but can go beyond to bridge health and education disparities. I joined the Brain Development and Education lab at Stanford after taking a medical break. During my break, I had the opportunity to run a vision screening camp for a school for differently abled children. Many children with a learning disability are misunderstood to have a vision problem making optometrist the first people to diagnose the disability but intervention stops at that point. This kindled my curiosity and I soon discovered the lack of converging understanding on the role of visual processing in dyslexia that in turn limits the possibility of evidence-based intervention. I was deeply interested in understanding the role of vision and attention in dyslexia. Over the past three years, I developed visual measures based on the most cited hypothesis in the dyslexia literature. These measures were designed such that they inform us about the hypothesized construct in an ecologically relevant paradigm for reading. I developed a validation scheme where measures are first deployed on the adult population and various behavioral and eye tracking aspects of the measure are characterized. The measures are built on a browser-based platform (using PsychoPy© and jsPsych©) where they are validated against the laboratory-based measurements. All the web-based visual measures have timing parameters optimized to ensure measurement validity. Over the past year, I have focused on optimizing these visual measures to make them adaptive, short, and reliable for kindergarten and first grade children. My goal in the current project is to leverage this battery of visual measures to understand how visual deficits are linked to the development of reading disorders. The web-based assessments are designed to be deployed to a large and diverse population of unprecedented scale.
-
Anoop Rao
Clinical Assistant Professor, Pediatrics - Neonatal and Developmental Medicine
Current Research and Scholarly InterestsWearable senors, unobtrusive vital sign monitoring, natural language processing/text mining
-
Rameshwar (Ram) Rao MD PhD
Postdoctoral Medical Fellow, Hematology-Oncology
Fellow in Pediatrics - Hematology & OncologyBioMy scientific training spans over a decade of published research in the fields of vascularized bone tissue engineering, biomineralization, gene therapy, and spectral ultrasound. I earned my BS from UC Davis and MS/PhD in Biomedical Engineering at the University of Michigan. I have aimed to form highly collaborative and multidisciplinary research groups at each level of training. This work has resulted in 21 publications, award-winning manuscripts, and multiple national conference research awards. My successful research career began during my undergraduate studies where my work in Prof. Kent Leach’s lab resulted in 3 publications and the Department of Biomedical Engineering Outstanding Undergraduate Research Award. My graduate thesis under the guidance of Prof. Jan Stegemann resulted in 12 publications (7 as first author) in high quality, peer-reviewed journals in the fields of engineering and biotechnology. My graduate studies were funded by an NIH T32 Training grant and the NSF Graduate Research Fellowship. My graduate work culminated in the 2013 Outstanding PhD Research Award from the Society for Biomaterials (SFB) and the 2013 Outstanding Student Award from the Tissue Engineering and Regenerative Medicine Society (TERMIS). Recognizing the gap in translation of bioengineering research into clinical practice, I opted to pursue an MD at the University of Michigan to become the physician-scientist that identifies clinical problems, engineers the solution, and delivers it back to the patient to advance treatments and improve survival outcomes. My success continued through medical school with 4 clinical research manuscripts and Graduation with Distinction in Research, awarded to 10% of the class.
In the next phase of my training, I will complete my fellowship in Pediatric Hematology/Oncology at Stanford through the Accelerated Research Pathway by the American Board of Pediatrics. Prof. Sarah Heilshorn, Associate Chair of Materials Science at Stanford, will be my primary research and career development mentor. Together, we have designed an innovative approach targeting the extracellular matrix to improve survival outcomes in pediatric osteosarcoma. -
Lindsey Rasmussen
Clinical Associate Professor, Pediatrics - Critical Care
Clinical Associate Professor (By courtesy), Neurology & Neurological SciencesCurrent Research and Scholarly InterestsMy research interests reside in the field of Neurocritical Care Medicine. My research focus has included inflammation following traumatic brain injury, outcome prediction after cardiac arrest, and neuro-monitoring in the pediatric intensive care setting. These interests are integrated clinically to focus on the merging of specialized neurologic monitoring and care with prognostic efforts in critically ill patients.
-
Caroline E. Rassbach
Clinical Professor, Pediatrics
Clinical Professor, Emergency Medicine
Clinical Professor, Emergency MedicineCurrent Research and Scholarly InterestsMedical education including learner assessment, program development and mentoring and coaching in medicine.
-
Noga Ravid
Clinical Assistant Professor, Pediatrics
Current Research and Scholarly InterestsChildren with medical complexity, medical education.
-
Sheila Razdan
Affiliate, Dean's Office Operations - Dean Other
Fellow in Pediatrics - Neonatal and Developmental MedicineBioNeonatal-Perinatal Medicine Fellow
-
Sushma Reddy
Associate Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsMy laboratory's expertise in cardiovascular phenotyping has led to the development of mouse models of congenital heart disease that recapitulate abnormal loading conditions on the heart. We have used these models to advance our understanding of the mechanisms of right heart failure in children and adults with congenital heart disease with the long term goal of identifying noninvasive diagnostic tools to better assess right ventricular health and to develop right ventricle specific therapeutics.
-
David Rehkopf
Associate Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Sociology and of Pediatrics
BioI am a social epidemiologist and serve as an Associate Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.
I am currently the co-director of the Stanford Center for Population Health Sciences. In this position I am committed to making high value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.
My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.
Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes. -
Agnes Reschke
Affiliate, Dean's Office Operations - Dean Other
Fellow in PediatricsBioAgnes Reschke, MD is a clinical fellow in the Division of Pediatric Hematology and Oncology at the Lucile Packard Children's Hospital, Stanford University School of Medicine. She obtained her bachelor of science and honors from Villanova University and after her family moved to Kentucky, went on to medical school at University of Kentucky College of Medicine. She completed a pediatric residency at Connecticut Children's Medical Center and during that time, focused on a clinical research project evaluating a proposed association between domestic radon levels and the development of sarcoma. Dr. Reschke ultimately came to Lucile Packard Children's Hospital for her pediatric hematology/oncology fellowship and during that time, discovered the emerging field of onco-critical care. Her fellowship research is in the lab of Tim Cornell, chief of pediatric critical care at Stanford. She is working to apply a real-time assay to measure cytokines in subsets of pediatric oncology patients to guide immunomodulatory therapies. By gaining a better understanding of these patients’ immune responses in real time, she believes that we will open the door for precision immunomodulatory therapy to treat critically ill patients, especially those experiencing sepsis or cytokine release syndrome. After completion of her hematology/oncology fellowship, Dr. Reschke will be pursuing a pediatric intensive care fellowship with the hope of becoming a leader and pioneer in onco-critical care.
-
William Rhine
Professor of Pediatrics (Neonatology)
On Partial Leave from 05/16/2023 To 03/09/2024Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.
-
Brian Richter
Administrative Services Manager, Pediatrics - Gastroenterology
Current Role at StanfordAdministrative Services Manager, Department of Pediatrics, Division of Gastroenterology, Hepatology, & Nutrition
-
Tawna L. Roberts, OD, PhD
Associate Professor of Ophthalmology (Pediatric) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsOur research efforts are funded by grants from the National Eye Institute, Department of Defense, and various foundations to study vision development in infants and young children as well as binocular vision disorders in adolescents and adults with concussions. Our focus is to identify underlying mechanisms that will inform clinical treatment approaches and ultimately leading to the prevention of strabismus, amblyopia, and binocular vision disorders.
-
Terry Robinson
Associate Professor of Pediatrics (Pulmonary) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research interests focus on detection of early and progressive Cystic fibrosis (CF) structural lung disease by utilizing chest CT imaging and CT post-processing methodology. Current research efforts involve utilization of low dose infant & children CT imaging protocols and quantitative airway and air trapping algorithms to evaluate early and progressive CF disease.
-
Thomas Robinson
The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.
-
Eunice Rodriguez
Associate Professor (Teaching) of Pediatrics (General Pediatrics)
Current Research and Scholarly InterestsCurrent program of teaching and research integrates: 1) health disparities and social epidemiology, within the broader area of public health, and 2) program evaluation, as a synthesis of theory and methods applied to the evaluation of health and social programs.
-
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine and Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
On Leave from 03/01/2023 To 02/29/2024Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants. -
Lisa Goldman Rosas
Assistant Professor (Research) of Epidemiology and Population Health and of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics
BioLisa Goldman Rosas, PhD MPH is an Assistant Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in chronic diseases such as diabetes, heart disease, depression, and cancer among racial/ethnic minority families. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners. She is passionate about integrating patients, caregivers, community organizations, and other key stakeholders in the research process in order to affect the greatest improvements in health and well-being. As a reflection of this passion, Dr. Goldman Rosas serves as the Faculty Director for the School of Medicine Office of Community Engagement, Co-Director of Community-Engaged Research for the Office of Cancer Health Equity, and Director of the Outreach, Recruitment and Engagement Core for the Alzheimer's Disease Research Center. In these roles, she supports other faculty and patient and community partners to develop sustainable and meaningful partnerships to support transformative research. In addition to research, she teaches at the undergraduate and graduate levels and has a special focus on increasing diversity in biomedical research.
-
Michael J Rosen, MD, MSCI
Stanford University Endowed Professor for Pediatric IBD and Celiac Disease
BioI am a pediatric gastroenterologist and physician scientist, who has been devoted to inflammatory bowel disease (IBD) research since beginning medical training over 20 years ago. I am also Director of the Stanford Center for Pediatric IBD and Celiac Disease. I have expertise crossing mucosal immunology and epithelial biology, formal training and experience in clinical and translational investigation with human biospecimens, and direct insight regarding the important clinical challenges caring for children with complicated IBD. My translational research program focuses on how the immune system regulates epithelial function in chronic intestinal inflammation as it relates to IBD. My clinical research program has focused on optimization of anti-TNF therapy in pediatric IBD, and in particular acute severe ulcerative colitis (ASUC). My laboratory has demonstrated a protective role for IL33, a cytokine that induces type 2 cytokines from T cells an innate lymphoid cells (ILCs), in acute oxazolone colitis through preservation of epithelial goblet cells and barrier function. In line with this finding, we have also shown in a large prospective patient cohort that mucosal expression of type 2 and type 17 immune response genes distinguishes ulcerative colitis (UC) from colon-only Crohn’s disease, and that type 2 gene expression is associated with superior clinical outcome in pediatric UC. We have now developed an organoid-immune cell in vitro culture system to demonstrate the ILC2-dependent mechanism through which IL33 induces goblet cell differentiation in the intestinal epithelium. I led the multicenter study Anti-TNF for Refractory Colitis in Hospitalized Children (ARCH) Study, which aims to establish determinants of anti-TNF response in pediatric ASUC and currently Co-Chair the Crohn's & Colitis Foundations Cohort for Pediatric Translational and Clinical Research in IBD (CAPTURE IBD) and PRO-KIIDS Pediatric IBD clinical research network.
-
David Rosenthal
Professor of Pediatrics (Pediatric Cardiology)
Current Research and Scholarly InterestsResearch interests include the study of Heart Failure, Cardiomyopathy and ventricular dysfunction in children, from a clinical perspective. Investigations include clinical trials of medications, cardiac resynchronization, and mechanical circulatory support.
-
Charlene Larson Rotandi
Associate Director of Fellowship Education, Pediatrics
BioI am currently the Associate Director of Fellowship Education in the Office of Pediatric Education. Most recently, I was the Department Fellowship Manager for the Department of Pediatrics, and prior to that I was the Fellowship and Postdoctoral Administrator in the Department of Pediatrics, Hematology/Oncology at Stanford University School of Medicine. Other positions I have held included Pediatric Residency Coordinator for Lucile Packard Children’s Hospital at Stanford University and the Graduate Medical Education Coordinator for the Department of OB/GYN and Reproductive Sciences at the University of California, San Francisco.
I am actively engaged in the Association of Pediatric Program Directors (APPD), currently serving on the Mentoring Work Group for the Coordinators’ Executive Committee. I’ve collaborated on a number of scholarly activities with fellow APPD colleagues in the area of professional empowerment and advancement of coordinators, coordinator wellness, program evaluation committees and annual program evaluations, clinical competency committees and milestones, as well as presented a fellow/faculty development workshop on milestones and assessment tools for our division. I continue to seek out opportunities to collaborate, mentor, and take on leadership positions.
Outside of graduate medical education, I am the mother of a very active and curious seven year-old. I also enjoy spending time with my family exploring the Bay Area, hiking, cooking, and enjoying food and wine and the vibrant arts culture. A brief stint as a pastry cook, I love to cook and bake with my son. Additionally, I continue to be involved in my alma mater, Vassar College, by co-chairing the Vassar Alumnae/i Admissions Program in San Francisco. -
Stephen J. Roth
Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsRandomized Therapeutic Trials in Pediatric Heart Disease, NIH/U01 GrantNo. HL68285 2001-2006.
Heparin and the Reduction of Thrombosis (HART) Study. Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.
A Pilot Trial fo B-type Natriuretic Peptide for Promotion of Urine Output in Diuretic-Resistant Infants Following Cardiovascular Surgery.Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006. -
Christopher John Russell
Associate Professor of Pediatrics (Hospital Medicine)
BioDr. Russell is an Associate Professor of Pediatrics in the Division of Pediatric Hospital Medicine and a board-certified academic pediatric hospitalist at Lucile Packard Children’s Hospital. His clinical responsibilities include caring for children hospitalized for a variety of illnesses. His research focuses on developing evidence-based care for hospitalized children with medical complexity, including acute respiratory infections (such as pneumonia and bacterial tracheitis) in children with medical complexity. His research efforts have been recognized through receipt of the University of Southern California’s Clinical and Translational Science Institute’s KL2 Mentored Research Career Development Award (2014-16), the Academic Pediatric Association’s Young Investigator Award (2015-16), the NIH Loan Repayment Program (2017-2021) and a large grant from the Gerber Foundation (2020-2022). In August 2021, he received a five-year R01 award from the Agency for Healthcare Research and Quality to study bacterial respiratory infections in child with tracheostomy. Outside of his clinical and research responsibilities, Dr. Russell focuses on research mentorship of medical students, pediatric residents, and pediatric hospital medicine fellows as well as improving representation of underrepresented minorities in medicine throughout the continuum of physician training. Dr. Russell is the chair of the Academic Pediatric Association’s Membership, Diversity, and Inclusion Committee and is on the Executive Committee for the Pediatric Research in Inpatient Settings research network. Dr. Russell is active in the AAP and currently serves as an Associate Editor for the journal Hospital Pediatrics.
